Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.

Ghiringhelli F, Vincent J, Bengrine L, Borg C, Jouve JL, Loffroy R, Guiu B, Blanc J, Bertaut A.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2357-2363. doi: 10.1007/s00432-019-02970-8. Epub 2019 Jul 4.

PMID:
31273511
2.

Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies.

Boglione-Kerrien C, Picard S, Tron C, Nimubona S, Gangneux JP, Lalanne S, Lemaitre F, Bellissant E, Verdier MC, Petitcollin A.

J Cancer Res Clin Oncol. 2018 Jan;144(1):127-134. doi: 10.1007/s00432-017-2523-2. Epub 2017 Sep 20.

PMID:
28932906
3.

Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.

Erice O, Labiano I, Arbelaiz A, Santos-Laso A, Munoz-Garrido P, Jimenez-Agüero R, Olaizola P, Caro-Maldonado A, Martín-Martín N, Carracedo A, Lozano E, Marin JJ, O'Rourke CJ, Andersen JB, Llop J, Gómez-Vallejo V, Padro D, Martin A, Marzioni M, Adorini L, Trauner M, Bujanda L, Perugorria MJ, Banales JM.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1335-1344. doi: 10.1016/j.bbadis.2017.08.016. Epub 2017 Sep 13.

4.

Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells.

Le Gac G, Angenard G, Clément B, Laviolle B, Coulouarn C, Beloeil H.

Anesth Analg. 2017 Nov;125(5):1600-1609. doi: 10.1213/ANE.0000000000002429.

5.

SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.

Merino-Azpitarte M, Lozano E, Perugorria MJ, Esparza-Baquer A, Erice O, Santos-Laso Á, O'Rourke CJ, Andersen JB, Jiménez-Agüero R, Lacasta A, D'Amato M, Briz Ó, Jalan-Sakrikar N, Huebert RC, Thelen KM, Gradilone SA, Aransay AM, Lavín JL, Fernández-Barrena MG, Matheu A, Marzioni M, Gores GJ, Bujanda L, Marin JJG, Banales JM.

J Hepatol. 2017 Jul;67(1):72-83. doi: 10.1016/j.jhep.2017.02.017. Epub 2017 Feb 22.

6.

Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.

Giménez-Mascarell P, Oyenarte I, Hardy S, Breiderhoff T, Stuiver M, Kostantin E, Diercks T, Pey AL, Ereño-Orbea J, Martínez-Chantar ML, Khalaf-Nazzal R, Claverie-Martin F, Müller D, Tremblay ML, Martínez-Cruz LA.

J Biol Chem. 2017 Jan 20;292(3):786-801. doi: 10.1074/jbc.M116.759944. Epub 2016 Nov 29.

7.

S-Adenosylmethionine and methylthioadenosine inhibit β-catenin signaling by multiple mechanisms in liver and colon cancer.

Li TW, Peng H, Yang H, Kurniawidjaja S, Panthaki P, Zheng Y, Mato JM, Lu SC.

Mol Pharmacol. 2015 Jan;87(1):77-86. doi: 10.1124/mol.114.095679. Epub 2014 Oct 22.

8.

Methionine metabolism and liver disease.

Mato JM, Martínez-Chantar ML, Lu SC.

Annu Rev Nutr. 2008;28:273-93. doi: 10.1146/annurev.nutr.28.061807.155438. Review.

PMID:
18331185
10.
11.

Supplemental Content

Loading ...
Support Center